KL
Kalaris Therapeutics Inc (KLRS)
NASDAQ·Healthcare·Biotechnology
$4.24
+4.69%
Mkt Cap $65.65M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$18.25
Range $14.00 – $23.00
Implied Upside
+330.4%
Consensus $18.25 vs current $4.24
NASDAQ·Healthcare·Biotechnology
$4.24
+4.69%
Mkt Cap $65.65M
No recent rating data.
Price Target (5 analysts)
$18.25
Range $14.00 – $23.00
+330.4%
Consensus $18.25 vs current $4.24